Aberrant SYT11 expression mainly affected the improved prognosis of overall survival (OS) for patients with KIRC (p = 0.00088) and LUAD (p = 0.0053), whereas high SYT11 expression was associated with poor prognosis for patients with ACC (p = 0.054), BLCA (p = 0.05), LAML (p = 0.023), MESO (p = 0.0036), and UVM (p = 0.023) (Fig. 2A). The gene discussed is SYT11; the disease is adrenal cortex carcinoma.